Related by context. All words. (Click for frequent words.) 91 Fodosine TM BCX 72 forodesine hydrochloride BCX 62 rheumatoid arthritis thrombocytopenia 61 Azedra TM Onalta TM 61 inflammatory autoimmune diseases 61 Asentar TM 61 forodesine HCl 60 LOMUCIN TM 60 CORLUX CORT # 59 Zemiva TM Trofex TM 59 vernakalant oral 57 Allovectin 7 R 57 highly purified pasteurized 57 XL# XL# XL# XL# 57 BioSante licensees 56 Clearant Process ® 56 XL# anticancer compounds 56 HuCAL PLATINUM ® CysDisplay 56 TRIOLEX HE# APOPTONE HE# 56 pentadentate logo R 56 fwiggins@progress-index.com 55 CholeraGarde R Peru 55 PEG PAL PEGylated recombinant 55 orBec ® oral beclomethasone 55 Generx TM 55 Restoraderm R 54 polymer platinate 54 refractory chronic lymphocytic 54 dihydrochloride Phase 3 54 valtorcitabine 54 TP# CETi 1 54 AzaSite Plus 54 jclay@herald-leader.com 54 candidate XP# 54 XP# XP# 54 novel L DOS# 54 oral calcitonin 54 EVIZON TM squalamine lactate 54 vernakalant iv 54 Soliris TM eculizumab 54 Eligard R 54 CoTherix logo 54 RAPTIVA R 53 developing ostarine selective 53 EGRIFTA TM 53 Modrenal R 53 Rexahn licensees 53 peramivir clinical trials 53 racial slurs harassment 53 contacting Kika Stayerman kika.stayerman 53 Dyax logo 53 assigns transferee 53 vii Cubist ability 53 RapMAT ® 52 OmniComm intends 52 TriPath Oncology 52 Entereg R 52 product BioThrax ® 52 Antigen Express website 52 xenograft implants 52 Exelbine 52 Canvaxin TM 52 Auxilium anticipates 52 developing ACAPODENE 52 Fortical ® 52 commercialized DURECT 52 JOULFERON 52 e mail cdevries@thedailymail.net 52 Pharmacopeia Phase 51 Cellegesic 51 SUPPRELIN LA DELATESTRYL 51 mGluR2 mGluR4 mGluR5 mGluR7 51 successfully commercialized 51 R roscovitine CDK cyclin 51 crinobulin 51 cbagley@californian.com 51 5 lipoxygenase inhibitor 51 advance Debio 51 Locteron exclusively 51 SANCTURA SANCTURA XR VANTAS 51 markets HP Acthar 51 novel MetAP 2 51 Azixa TM 51 drug ISA# 51 CONTAINS FORWARD LOOKING STATEMENTS 51 novel synthetic PEGylated 51 cardinals donned Delly 51 incorporate CXA 50 e mailing letters@jacksonville.com 50 repopulate CNS 50 AcryMed technologies 50 TRISENOX ® 50 tivozanib AV 50 retransmitting broadcasting 50 lewd racist 50 Allovectin 7 r 50 Acetavance TM 50 Phase IIa clinical trials 50 gastrointestinal disorders ATI 50 SECTION #A OF 50 NetVault Application Plugin 50 Kosan dependence 50 STRIANT ® 50 novel proprietary KL4 50 website www.corcept.com 50 MSBlast exploits flaw 50 AND ORAL STATEMENTS MADE 50 SAFE HARBOR PROVISIONS OF 50 transgenically produced product 50 crolibulin TM 50 further reassort 50 commercializing Loramyc ® 50 Shire Attention Deficit 50 Evoltra ® 50 SearchHelp communications 49 Mr. Gharapetian 49 BY REPRESENTATIVES OF 49 DIFICID ™ 49 find torrents keygens 49 MAXY alpha 49 Solzira TM 49 print electronically 49 obscenity pornography advertising 49 Symphony tCGM 49 uncertainties materializes FICO 49 PerClot 49 Aphthasol R 49 Increlex TM 49 THE PRIVATE SECURITIES LITIGATION 49 Letters submission form 49 proprietary Capillary Aerosolization Technology 49 negatives thereof 49 oral transdermal 49 OF SECTION #A 49 neurosurgery laparoscopic surgery 49 constituteforward looking 49 Pruvel ™ prulifloxacin 49 partner lorcaserin APD# 49 UNITED STATES PRIVATE SECURITIES 49 Safe Harbors created 49 reproduced redistributed 49 dneuses@qconline.com 49 IS FOR INFORMATIONAL 49 subsidiaries visit http:/www.apricusbio.com 49 THE INFORMATION PROVIDED 49 timelines communicated 49 TO IDENTIFY SUCH FORWARD 49 FACTIVE R gemifloxacin 49 R rilonacept Injection 49 commercialize NicVAX 49 PROVISIONS OF THE PRIVATE 49 THE AUCTIONEER RESERVES 49 novel emulsion formulation 49 biomimetics non 48 successfully commercialize Iluvien 48 OctoPlus licensed 48 WITHDRAW ANY ITEM 48 See www.chdtcorp.com 48 develop PS# 48 OraDisc TM 48 THE WINDS WILL 48 At PalmBeachPost.com 48 induce diuresis 48 reflecting Achillion 48 ARE MADE AS 48 visit www.bioject.com 48 INCLUDED IN THIS 48 WITHIN THE MEANING OF 48 Nicotine Conjugate Vaccine 48 BioGlue R 48 use profanities vulgarities 48 commercialize ZYFLO CR 48 UNITED STATES SECURITIES ACT 48 WEB SITE OR 48 EMPOWER pivotal trial 48 Nothing vulgar obscene 48 miconazole MBT 48 SiliconSystems logo 48 Reader Reaction These 48 ZALBIN 48 allow advertising proselytizing 48 Staphylococcus aureus Immune Globulin 48 Alnylam dependence 48 obscene hateful racist 48 chemosaturation system 48 ONCE AVAILABLE 48 PURPOSE OF SAFE HARBOR 48 StarNet www.azstarnet.com may 48 defame threaten 48 MAY DIFFER 48 MGCD# MGCD# [002] 48 vinorelbine emulsion 48 AS ESTIMATE ANTICIPATE BELIEVE 48 PLAN OR EXPECT 48 Tostrex 48 Insufficiently supportive policies 48 On SoftSailor 48 Rectogesic 48 Safe Harbors provision 48 BY THESE FORWARD 48 BLA submission 48 treat refractory angina 48 REPORTS FILED FROM 48 WHICH ARE NOT PURELY 48 Prochieve R 48 theseforward looking 48 successfully commercialize Silenor 48 STATEMENTS WITHIN THE MEANING 48 Fast Track designation 48 Playback Organizer Renaissance Scenario 48 wound debridement cosmetic surgery 48 MGCD# MGCD# [001] 48 ARE NOT INDICATIVE OF 48 NeoLipid drug 48 Entereg TM 48 Orphan Drug designations 48 publications copyrights 48 Kosan motilin agonist 48 VANTAS 47 Somatuline R Depot 47 DEBT AND IDENTITY 47 contact pkamdar@resourceamerica.com 47 By Gabriel Rizk 47 YOU OUT THERE 47 STATEMENT CAREFULLY WHEN 47 Chaim Lebovits President 47 MAY CONTAIN FORWARD LOOKING 47 manufacture PolyHeme 47 party payor reimbursement 47 Fampridine SR Acorda Therapeutics 47 OR INFORMATION 47 without limitation Newlook 47 RISK FACTORS DISCLOSED IN 47 AND ARE SUBJECT 47 THE COMPANY AND 47 AMY ® MYNX 47 encourage collegial non 47 Metabasis stockholders 47 ARE STRONGLY ADVISED TO 47 MANAGEMENT 'S CURRENT BELIEFS 47 Reporter Kurt Bresswein 47 Preakness Impeachment 47 Biologic License Application BLA 47 variation thereon 47 commercialize telaprevir 47 PentaStaph 47 HISTORICAL ARE FORWARD LOOKING 47 ALL WARRANTIES EXPRESS 47 AnGes 47 STATEMENT WHEN IT BECOMES 47 IS DEFINED IN 47 involving hydrophilic liquid 47 Biologics License Application 47 THE STATEMENTS WHICH 47 free E Newsletters 47 OFFER TO PURCHASE LETTER 47 Thalomid R 47 defamatory obscene abusive 47 Gestiva TM 47 faropenem 47 PURPOSES ONLY AND DOES 47 WILL PROVE TO BE 47 STRIANT R 47 obscene abusive profane 47 http:/www.nansulate.com 47 IN SUCH FORWARD 47 ECONOMIC EVALUATIONS AND 47 valopicitabine 47 Legislation Reform Act 47 v Nastech 47 DATA ARE FORWARD 47 gastrointestinal GVHD include 47 Affymetrix logo 47 proprietary capillary aerosolization 47 ® REFLEXX ® MICROVISTA 47 aEURoeanticipatesaEUR aEURoedraftaEUR aEURoeeventuWainohu 47 OR OTHER EXPECTATIONS IMPLIED 47 OR SIMILAR STATEMENTS ARE 47 subsidiaries InnerCool Therapies 47 ® UV REPREVE 47 SHAREHOLDERS CONCERNING FORWARD LOOKING 47 testosterone buccal system 47 hoFH 47 update anyforward looking 47 WAS PREPARED BY KINBAURI 47 e mail jloewenstein@thedailyreview.com 47 variations thereon 47 At pbpulse.com 47 performance yarns SORBTEK 47 historicalfacts 47 RXi Pharmaceutical Corporation 47 bardoxolone 47 THOSE CONTAINED IN 47 render PolyHeme obsolete 47 TO ACHIEVING CORPORATE OBJECTIVES 47 Auxilium assessments 47 INCLUDE ANY STATEMENTS REGARDING 47 Biological License Application 47 Acura Buick Cadillac 47 Misonix proprietary ultrasonic 47 www.biospecifics.com 47 ADVISOR ® 47 PLAYLOGIC assumes 47 MASSON • 47 By JOE STEVENSON 47 email letters@usatoday.com 47 unsubstantiated rumors obscenity pornography 47 VERIFICATION OF THE 47 max@politicsnj.com 46 5 NorthEscambia.com reserves 46 PLACE UNDUE RELIANCE ON 46 @ Mobilewhack 46 john.valenti @ newsday.com 46 Reproduction retransmission 46 DANNY REITER 46 defamatory racist homophobic 46 www.norsat.com 46 AND SHOULD ALSO 46 OvaRex ® MAb 46 Cutanea Life Sciences 46 considered libelous defamatory 46 Through Glycoscience R 46 YOU IN RELIANCE 46 STATEMENTS RELATING TO 46 sNDAs 46 PINPOINT SPY scope 46 jurisdiction Howman 46 BioGlue ® 46 WHEN YOU WERE DOWN 46 AVAILABLE BECAUSE THEY CONTAIN 46 ability tosuccessfully 46 include extracranial tumors 46 included Pentaerythritol tetranitrate 46 SHALL NOT CONSTITUTE AN 46 Pixelplus cautions readers 46 AFFECT MICROSEMI 'S 46 ANY WAY WITHOUT 46 Nortel disclaims 46 AND RELATED MATERIALS BECAUSE 46 Cancel anytime 46 Premier Exhibitions disclaims 46 any copying redistributing 46 Powerwave logo 46 website www.competitivetech.net 46 Argatroban 46 CONTAINS CERTAIN FORWARD LOOKING 46 WITH THE BENEFIT 46 Rosetta dependence 46 affect Pennichuck Corporation 46 Rotarix R 46 Commissions trailing 46 john@stockguru.com 46 BY KEIKO MORRIS keiko.morris 46 nonhematologic adverse reactions 46 GenVec cautions 46 STATEMENTS AND 46 Reviewing Feature 46 Moneylife.in website 46 Miraculins cautions 46 CONTAIN FORWARD LOOKING STATEMENTS 46 INCLUDES FORWARD LOOKING STATEMENTS 46 THE COMPANY UNDERTAKES NO 46 OR ACHIEVEMENTS IMPLIED 46 IMPACT OF CHANGES 46 AND FUTURE EVENTS 46 SILENOR TM 46 BY CYNTHIA HOWELL ARKANSAS 46 MAb therapy 46 ad FROM wp tpt OpenAds 46 email sicity@intrstar.net 46 Marketing Authorization Applications 46 language deemed unfit 46 PLACE UNDUE IMPORTANCE ON 46 ITS REGULATION PROVIDER AS 46 Digium Asterisk Asterisk 46 viewpoints race 46 IN OTHER PUBLICLY 46 THELIN 46 Datamonitor shall 46 THAT INCLUDE SUCH WORDS 46 paste articles 46 Poly ICR 46 Receive mediabistro.com s 46 http:/www.celera.com 46 eprodisate KIACTA TM 46 damage cirrhosis liver 46 BY MAKING THESE 46 racism heterosexism classism religious 46 Loramyc TM 46 RELIANCE UPON ANY FORWARD 46 disease affects cloven 46 affect Petroflow 46 Gentamicin Surgical Implant 46 permits consents 46 THAT ARE NOT SENT 46 See http:/www.chdtcorp.com 46 Daily FishbowlDC Feed 46 AND OTHER INTERESTED PARTIES 46 E mail newstips 46 GLASSIA ™ 46 THE COMPANY TO BE 46 THAT YOU GUYS 46 website http:/www.depomed.com 46 FOR INFORMATIONAL PURPOSES ONLY 46 mergers dispositions 46 Daily TVNewser Feed 46 ON SUCH DOW JONES 46 THE ADEQUACY OR 46 HAS BEEN PREPARED BY 46 BY RYAN ERNST 46 Pharmos pipeline 46 INFORMATION INCLUDING THE TERMS 46 VYVANSE TM lisdexamfetamine 46 STATEMENTS IN 46 RECEIVED OR EXECUTED 46 BY SUCH FORWARD 46 INVESTORS SHOULD NOT 46 Shire plc Attention Deficit 46 commercialize CorMedix drug 46 Delta Kenty nickel 46 http:/www.optimerpharma.com 45 Numerex cautions 45 Ceragenin ™ technology 45 Note SHIPPING CHARGES 45 RESULTS INDICATED OR IMPLIED 45 Fast Track designations 45 READERS SHOULD NOT 45 UNCERTAINTIES OR OTHER 45 plastic polymer preforms 45 OxyContin Chernoff 45 BY ALEXANDER COOLIDGE 45 Synerx 45 BY CHARLIE MORASCH ARKANSAS 45 lowdown Mickey Spillane 45 ZEGERID Chewable Tablets 45 CONTAINED IN THIS 45 www.thallion.com 45 orBec R 45 SIMILAR EXPRESSIONS ARE INTENDED 45 http:/www.thqwireless.com 45 visit www.solitaireminerals.com 45 results performance orachievements 45 AcryMed Incorporated 45 IS NOT INDICATIVE OF 45 THOUGHTS EXPRESSED HEREIN WITHOUT 45 acquisitions divestitures mergers 45 ACTION TAKEN BY 45 ENTIRETY BECAUSE THEY CONTAIN 45 Somatuline R Autogel R 45 e mail earthtalk@emagazine.com 45 Nabi HB Intravenous 45 contact PRWeb 45 jgosche@advertiser-tribune.com 45 Please LOGIN 45 BY BRIAN BASKIN ARKANSAS 45 risks anduncertainties 45 PINNACLEDIGEST.COM S PAST PERFORMANCE 45 AnalogicTech logo 45 OR ANYONE ELSE FOR 45 GUESS ALL JENS FRIENDS 45 BY ANDY PIPER 45 IS NOT AN OFFER 45 Westerplatte glory 45 ANY SHARES 45 website www.advbiomaterials.com 45 Urokinase 45 Commentary submitted 45 NANCY WOOD 45 BY KAT O'BRIEN kat.obrien 45 OR USE 45 'S FUTURE PLANS 45 BY JOHN ERARDI 45 BE HELD RESPONSIBLE FOR 45 joann@theacorn.com 45 info@newstream.com 45 Nycomed GmbH 45 www.sanofipasteur.us 45 BY JAMES MCNAIR 45 DISCLOSURE NOTICE 45 Suchforward looking 45 REFORM ACT OF 45 ruxolitinib 45 Sports Writer paulg@nwanews.com 45 ANY DECISION MADE OR 45 OR REVISE ANY FORWARD 45 BY DREW SHARP 45 MATERIALLY FROM ANY FUTURE 45 BY RAFER GUZMÁN rafer.guzman 45 Daily FishbowlLA Feed 45 Microwave Fiber TM 45 SECURITIES COMMISSION OR OTHER 45 forward lookinginformation 45 THESE STATEMENTS FOR REVISIONS 45 BY CAROL CAIN 45 difficulties foreseeing 45 Kalamazoo newsroom 45 Daily Trojan deems 45 ACCORDINGLY READERS SHOULD NOT 45 PUBLIC WEBSITE WWW.FITCHRATINGS.COM 45 MONOVISC 45 general Eventful user 45 events thrombocytopenia neutropenia 45 looking statements includingbut 45 researches develops licenses 45 TechRepublic NetNote member 45 #-hour/#-day cycle 45 dsm.com e mail 45 Dona Harms managing 45 BY TRACIE DUNGAN ARKANSAS 45 Rufino Tamayo Francisco 45 European Marketing Authorizations 45 AND ASSUMPTIONS AND 45 law ZymoGenetics undertakes 45 OF AGRIUM AND 45 BE DELAYS OMISSIONS OR 45 BY JONATHAN SHUGARTS 45 e mail kokualine@staradvertiser.com 45 Company website www.nyandcompany.com 45 Inc Therapeutic Competitors 45 suchstatements 45 Juniper Networks logo 45 successfully commercialize 45 Copying Broadcast Republication 45 ComfortScan system 45 incur unanticipated 45 Review performance ofcialis 45 Moneylife Magazine 45 omissions therefrom 45 Marketing Authorisation Application 45 Boehringer Ingelheim CHDI Novartis 45 CAUTIONARY STATEMENT UNDER 45 Standard Messaging Rates 45 website www.nyandcompany.com 45 OBLIGATION TO REVISE OR 45 unregistered trademarks mentioned 45 www.vivakor.com 45 Likewise Stockwire.com 45 BY BRIAN DICKERSON 45 THE AUTHENTICITY OF 45 Acapodene R 45 Linjeta TM 45 html entity decode 45 Daily FishbowlNY Feed 45 Cytogen dependence 45 ARE USED THEY IDENTIFY 45 comments@manxradio.com 45 http:/www.thedailycamera.com./ Copyright c 45 non English curse 45 Cytogen periodic filings 45 CHANGES IN PROJECT PARAMETERS 45 TSX VENTURE GAP 45 THE BENEFIT OF HINDSIGHT 45 OF THE ORIGINAL 45 CHECK YOUR E MAIL 45 fowlerb@knews.com 45 NovaDel 45 typo email webmaster@northfulton.com 45 IS INTENDED FOR DISTRIBUTION 44 histamine dihydrochloride 44 SunSentinel.com joinus 44 FUTURE RESULTS 44 By RYAN BRINKS 44 telaprevir VX 44 KRYSTEXXA TM 44 INFORMATION CONTAINED HEREIN 44 #-#-# #ET Copyright c 44 Health RxList theHeart.org 44 NovAtel assumes 44 risksand uncertainties 44 CHDT undertakes 44 ADVISOR logo 44 WARNING Any unauthorized 44 BY NELL SMITH ARKANSAS 44 ON WHETHER HE 44 BY KATIE STRANG caitlin.strang 44 BY RICK FIRES ARKANSAS 44 defame threaten abuse 44 forward lookingstatements 44 rnapper@bradenton.com 44 objectives therefor 44 THE OPTION MAY 44 ACAPODENE R 44 BLUE PUMPKIN logo EXAMETRIC 44 THAT THEY ARE DESIGNED 44 BY DAVID KRECHEVSKY 44 Daily GalleyCat Feed 44 AFFILIATES AGENTS OR LICENSORS 44 Vitaros R 44 internet website www.mcmoran.com 44 TOP THREE LINKS YOU 44 STATEMENTS CONCERNING PLANS OBJECTIVES 44 scassi@express-times.com 44 dimesylate Attention Deficit 44 unfairly interferes 44 BY EMI ENDO 44 Seabridge cautions 44 BY STACEY ALTHERR stacey.altherr 44 LOPROX R 44 THE RESULTS PERFORMANCE 44 submit tribblet using 44 news@wsmv.com 44 BY DAVID ASHENFELTER 44 ANY OF ITS AFFILIATES 44 GSI Commerce expressly disclaims 44 TSX VENTURE PPY.A TSX 44 FOR REDEMPTION BY 44 BECKER Courant Staff Writer 44 xi Immtech ability 44 howardsmith@howardsmithlaw.com 44 ADVENTRX 44 OBLIGATION TO UPDATE 44 & PRODUCT DEFINITIONS 44 visit www.eveningnews#.co.uk/forums 44 DC Bead 44 Medtronic Annual Report 44 NitroMed BiDil 44 TSX VENTURE RM OTCQX 44 BY SAM COOPER 44 AFFILIATES AGENTS AND LICENSORS 44 Sunesis nonclinical studies 44 Statements Statements 44 mso padding alt 0cm 44 email info@unify.com 44 Floor Kafkasou 9 Aglantzia 44 futureevents 44 WITHOUT ANY WARRANTIES 44 need aditionalinformation please 44 your Pics Upload 44 helped popularize symphonic 44 EXPRESSED OR IMPLIED 44 www.medicago.com 44 marks referenced herein 44 BY JO ANN 44 Moneyweb Community 44 EPIX Pharmaceuticals 44 rapamycin derivatives 44 No racism sexism 44 . drip drip 44 AS THAT TERM 44 Neurobionix 44 New Feature Recommend 44 OR DISAPPROVED THE 44 nynewsday.com archives 44 Template Error loadfile While 44 Orphan Drug status 44 AVAILABLE AND 44 Gennum logo 44 Asterisk Appliance Genuine Asterisk 44 CAREFULLY READ THESE MATERIALS 44 Hilton Home2 Suites 44 OF TRANSMITTAL AND OTHER 44 GearUpForSports makes 44 Prelude SkinPrep Systems 44 DIFFERENCES BETWEEN HYPOTHETICAL PERFORMANCE 44 ALDA assumes 44 ACTUAL RESULTS COULD DIFFER 44 PowerPoint presentation audio 44 communicate differentiations effectively 44 OTHERS RISKS RELATED TO 44 TRUSTCASH 44 RESPONSIBILITY FOR THE ADEQUACY 44 BY MICHAEL PUFFER 44 historical facts areforward 44 TomoTherapy judgments 44 AND OBJECTIVES OR 44 differmaterially 44 involve racism sexism 44 INDIRECT INTERESTS BY 44 CSLR expectations 44 OPAXIO pixantrone 44 FOLLOWED BY OR 44 CPEX undertakes 44 CONCERNING FORWARD LOOKING STATEMENTS 44 Gilead assumes 44 GTC undertakes 44 THE SECOND TOWER 44 OF HINDSIGHT 44 Reporter Sarah Cassi 44 PolitickerME.com Reporter 44 CLX Investments 44 OTCBB IBPM 44 THAT ARE SUBJECT TO 44 Sie lesen Finanznachrichten und 44 articles d' IRIN 44 BY BILL MASON bill.mason 44 preference disability 44 Ceplene TM 44 BY KEVIN KELLY 44 ACCURATE AS ACTUAL RESULTS 44 proprietary punctal plug 44 While Ambrilia anticipates 44 InSite reliance 44 promote ceftobiprole 44 c SIGA 44 ACOOLIDGE@ENQUIRER.COM 44 PDL BioPharma logo 44 Ty# ETEC E. coli 44 BY CARRIE MASON DRAFFEN 44 party semiconductor foundries 44 BY PAUL HUGHES 44 FROM INDEPENDENT ACCESS 44 Corporation OTCBB SVUL 44 GLP toxicology studies 44 timing rescheduling 44 MethyPatch 44 defrocking clergy 44 Sleeping Giant mines 44 Evergreen Solar cautions 44 http:/www.thewallstreetleader.com 44 CLIPBOARD items 44 OTCBB FROI 44 SHALL CEP NEWS 44 looking statementsâ € 44 DSMA Smartstox content 44 ap online.com 44 WHICH WOULD 44 OF ARE URGED 44 NeoMagic circle 44 CAUTIONARY STATEMENT Certain 44 IN SOME CASES 44 BY JIM MOORE 44 FREE PRESS SPORTS WRITER 44 Enzon PEGylation technology 44 Forward lookingstatements 44 Biomerica contains 44 nothistorical facts 44 undiscovered accumulations 44 THE CALL WARRANTS 44 telecast webcast re 44 users slander coarse 44 StarNet reserves 44 forward.looking statements 44 source Novinite.com 44 popular ReaderRant discussion 44 Orbix R 44 PREPARATIONS TO PROTECT LIFE 44 QG1 44 Limited Nasdaq GRRF 44 NOT ACCEPT RESPONSIBILITY FOR 44 Idenix anticipates 44 theglobe.com inc 44 registeredtrademarks 44 EpiCept periodic reports 43 jkawa@cnc.com 43 http:/www.howardsmithlaw.com 43 EVENT TRANSCRIPT 43 BY SCOTT WARTMAN 43 MAY INCLUDE FORWARD LOOKING 43 taliglucerase alfa 43 ELEVESS 43 THIS EMAIL AND 43 BY HOWARD WILKINSON 43 BY RON DZWONKOWSKI 43 HYPOTHETICAL PERFORMANCE RESULTS 43 PolyHeme successfully 43 agriffin@courant.com 43 KeithsMoustache 43 THE POSSIBLE ADVERSE 43 Silicon Image logo 43 rbrundrett@thestate.com 43 info@adtran.com 43 QuoteMedia intends 43 TSX VENTURE YEL FRANKFURT 43 DISPLAY AND SEARCH THE 43 SIMULATED TRADING PROGRAMS IN 43 harass abuse 43 IN ADDITION RATING DEFINITIONS 43 regulatory authorizations 43 HEPLISAV 43 BigString Corporation intends 43 concerning Alnylam 43 Private SecuritiesLitigation Reform Act 43 strategic participations 43 Deregulation section details 43 QUALIFIED PERSONNEL AND 43 DTT NET.COM editor 43 JENNIFER ANISTONS GOOD FRIEND 43 R ROYAL VELVET 43 ENQUIRER CONTRIBUTOR 43 BEMA Granisetron 43 reflect GuestLogix 43 please visit www.PositiveIDCorp.com 43 CEFF financings subject 43 mysunshinecoast.com.au may 43 iii Cubist 43 Orphan Drug designation 43 BY DELTHIA RICKS delthia.ricks 43 candidate Ramoplanin 43 CoStar stent 43 infringed misappropriated invalid 43 projections anticipations 43 OR ACCURACY OF 43 http:/www.emporiagazette.com/pdf 43 AGREE WITH ANY OF 43 ONLY THE ORIGINAL 43 CTO POWER PANEL Where 43 payor acceptance 43 companies visit www.osi 43 kbresswein@express-times.com 43 Copying dissemination 43 Sainte Germaine Quebec 43 SECURITY HOLDINGS OR OTHERWISE 43 news.de ein Presseportal der 43 FACTIVE tablets 43 BY BILL BLEYER bill.bleyer 43 USERS ARE NOT ENDORSED 43 camouflage profanity 43 misspelling email programming@wclo.com 43 AND RECOMMENDED ACTIONS 43 affecting Amarin 43 SHALL THE LIABILITY OF 43 Oncolytics please 43 Orphan Drug Status 43 WILL DOW JONES ITS 43 Affiliate AKC organizations 43 RESULTS TO DIFFER 43 should consult NeurogesX 43 offer unsubstantiated facts 43 NOTE AnalogicTech 43 http:/www.macon.com Copyright c 43 onto cyanide heap 43 drawing painting gouache 43 AMAE SOFTWARE 43 e mail lifestyle@readingeagle.com 43 Service www.scrippsnews.com 43 SO WE DO 43 Standoutstocks.com profiles 43 bioengineered microspheres 43 anticipated drydocking 43 Mago ® 43 COPIED OR REPRODUCED IN 43 offerings visit www.balqon.com 43 jmonteverde@faruqilaw.com 43 aEURoeforward looking 43 subsequent amendments thereto 43 REGULATORY AUTHORITY HAS APPROVED 43 BY MICHAEL SCHMIDT 43 EHR Modules meet 43 THESE DOCUMENTS AND OTHER 43 SumTotal Systems filings 43 OF ORIGINALITY ACCURACY TIMELINESS 43 ATK undertakes 43 areforward looking 43 mbbaker@sunherald.com 43 Toreador intends 43 YOU SHOUTED YOUR COMMENT 43 dotPhoto.com 43 THE ISSUER IS AUTHORITATIVE 43 RESULTS PERFORMANCE OR ACHIEVEMENTS 43 THE INHERENT HAZARDS OF 43 please visit www.gnss.com 43 Kvitova keh VIT 43 CSLR caution 43 OF THE PROPOSED 43 UPDATE THESE FORWARD 43 ATTRIBUTING UNDUE CERTAINTY OR 43 TSX VENTURE KTX 43 # investor.relations @ 43 IS JENNIFER ANISTONS 43 reflect DTRO 43 commercialize StaphVAX 43 BY EMILIA ASKARI 43 misspelling email online@independentmail.com 43 SHALL NOT BE LIABLE 43 BY KEVIN LITTEN 43 By JULIE ZEEB 43 anything sexually explicit 43 AnorMED expectation 43 newsday.com archives 43 Newtek beliefs 43 Lamotrigine Tablets 43 BY CHRISTINE ARMARIO christine.armario 43 RECEIVE AN E MAIL 43 trading house.net AG 43 Corgenix diagnostic products 43 Private Securities Reform Act 43 CRINONE ® 8 43 Loramyc 43 kindly quote 43 ForexTV accepts 43 Nanobac Pharmaceuticals Inc. 43 LIVE INTERNET BIDS 43 Magicalia Sites 43 CLEAN Avoid language 43 MicroMacro ™ Multi 43 THEY CONTAIN IMPORTANT INFORMATION 43 e mail heather@smdailyjournal.com 43 word BREAK 43 PRIOR TO MAKING ANY 43 By EDMUND H. 43 PRELIMINARY JOINT PROXY STATEMENT 43 A. ERICKSON 43 BY ROBERT GEARTY 43 ZEGERID Powder 43 forwarda ^ looking 43 BY KEN BERGER 43 Woolhouse argues 43 Syntroleum Process 43 BE RESPONSIBLE OR 43 Deal Jeff Probst 43 BY VERNE GAY verne.gay 43 sublicense agreements 43 MedWatch website 43 +#- 0 -#-#-# APAC 43 EXPECTED RESULTS MAY INCLUDE 43 @ dtt net 43 Antigenics undertakes 43 Treppides Tower 6th 43 BY STEPHANIE A. WILKEN 43 Staff Writer bchatmon@opubco.com 43 APNB 43 HEREBY DISCLAIMS ANY SUCH 43 MPEH TM 43 THE INFORMATION FOUND 43 Powerwave Powerwave Technologies 43 A. WEBSTER 43 APakistanNews.Com 43 DYNACIN R Tablets 43 expressed orimplied 43 commercialization milestones 43 PROCHIEVE 43 PLX Technology logo 43 express Luminex 43 Systems CohesiveFT CSRware DataDirect 43 www.DearAbby 43 FREE PRESS BUSINESS 43 xii Immtech ability 43 CCR5 inhibitors entry 43 degrades another 43 Une sélection d' 43 Basic Subscription 42 currentexpectations 42 BY EILEEN MOZINSKI 42 James Bernstein james.bernstein 42 PR NEWSWIRE copy 42 differ materially fromthose 42 http:/www.freep.com Copyright c 42 similarexpressions 42 Vertex retains 42 PDAUGHERTY@ENQUIRER.COM 42 ImmuneRegen intends 42 Company TSX QEC 42 ONSOLIS 42 W. RHODES SUN 42 ACTUAL RESULTS MIGHT DIFFER 42 e mail Heloise@Heloise.com 42 Safe Harbor Disclosure 42 laws Petrominerales assumes 42 FROM USE OF 42 INCLUDING THE COMPANY 42 SMA Indústria Química SA 42 investigating pralatrexate 42 karin@valpolife.com 42 CERTAIN RISKS AND UNCERTAINTIES 42 BY RICK BRAND rick.brand 42 SECURITIES LITIGATION REFORM ACT 42 RISKS COULD CAUSE ACTUAL 42 statementsregarding 42 Thesestatements 42 OTHER THAN STATEMENTS OF 42 HAVE SHOWN 42 hyperpigmentation irregular 42 hbrubaker@phillynews.com 42 NOTE PDL BioPharma 42 Michelle Durand 42 text i Display 42 misspelling email watsond@timesrecordnews.com 42 causeactual results 42 By Daniel DeMaina 42 cdempsey@courant.com 42 Inovio pipeline 42 Comments flagged 42 Sticks Cream Cheese 42 skennedy@bradenton.com 42 ACCORDINGLY NO ASSURANCES CAN 42 SynthRx 42 Bilive TM 42 OR CONTINGENCIES BEYOND ITS 42 Playlogic assumes 42 Write Lemme Doit 42 L. NISSLEY 42 R galsulfase 42 dfujimoto@kauaipubco.com 42 VillageSoup Art Entertainment 42 BY BARRETT 42 Business Edition AsteriskNOW 42 Redline WiMAX products 42 BY SUCH STATEMENTS 42 Company Nasdaq RGDX 42 Hudsonhubtimes.com does 42 Junovan 42 info@m2.com 42 balbach@dailynewsgroup.com 42 EMILY C. DOOLEY 42 lender consents 42 Sports Writer tomg@nwanews.com 42 Wet Granular WETGR Loose 42 DO NOT BASE 42 BY ERICA MARCUS